Introduction: Takotsubo syndrome (TTS) is a stress-induced cardiomyopathy, but the
accurate cause of this syndrome is still unknown.
Methods: β-adrenergic agonist isoproterenol (ISO) is used to establish the TTS rats model. TTS
rats were treated with or without LY294002 or Rapamycin. The rat cardiomyoblast cell line H9C2
was subjected to infect with constitutively active Akt (myr-Akt) or dominant-negative mutant Akt
(dn-Akt) and then, treated with ISO. Cell apoptosis was assessed using the Bax/ Bcl-2 ratio. In addition,
reactive oxygen species (ROS) levels were measured using dihydroethidium (DHE). Mitochondrial
superoxide generation and membrane potential were assayed by MitoSOX and JC-1
Results: ISO might induce the erratic acute cardiac dysfunction and overexpression of
PI3K/AKT/mTOR. Moreover, it also increased the oxidative stress and apoptosis in TTS rats. The
Akt inhibitor significantly reversed the cardiac injury effect, which triggered by ISO treatment. In
H9C2 cells, the inhibition of Akt provides a protective role against ISO-induced injury by reducing
oxidative stress, apoptosis and mitochondrial dysfunction.
Conclusion: This study provided new insight into the protective effects of myocardial dysfunction
in TTS rats via chronic inhibition of the PI3K/AKT/mTOR expression, which could reduce mitochondrial
ROS and oxidative stress-induced apoptosis. PI3K/AKT/mTOR inhibitor could be a
therapeutic target to treat cardiovascular dysfunction induced by stress cardiomyopathy.